Reimbursed Care Access in Tuvalu

Currently classified as a strictly controlled substance under Tuvalu’s national drug and poisons legislation, with no authorised medical use or reimbursement outside of approved clinical research. Any importation or dealing in poisons and controlled substances is regulated under the Pharmacy and Poisons Act and the Dangerous Drugs Act, which require ministerial licensing for importation and sale and empower the government to add substances to the Poisons List by Gazette order # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Tuvalu’s statutory framework requires licences for importation and sale of poisons/controlled drugs and allows the Minister to prohibit importation of any drug deemed injurious to health # #.

Esketamine (the S-enantiomer nasal product marketed in some jurisdictions) is not known to have an approval, reimbursement pathway, or established medical programme in Tuvalu. There is no publicly available regulatory approval record or national treatment guideline authorising esketamine for psychiatric indications in Tuvalu; importation of any such medicine would be subject to the Pharmacy and Poisons Act licensing and Ministerial control and, if not explicitly licensed, could be prohibited from importation # #.

Ketamine is an established injectable anaesthetic listed on the WHO Model List of Essential Medicines and is widely used internationally for surgical and emergency anaesthesia; where a country’s health service uses ketamine for anaesthesia it is typically provided as part of routine hospital medicines rather than through a specialised psychedelic-treatment reimbursement pathway #.

In Tuvalu, the Pharmacy and Poisons Act provides the legal framework for importation, licensing and sale of medicines and poisons; medicines intended for bona fide medical treatment may be imported by qualified medical practitioners and registered pharmacists under that Act, and the Minister may prohibit importation of items deemed injurious to health or require licences for poisons on the Poisons List #. Princess Margaret Hospital (the country’s single national hospital) is the primary provider of medical and surgical services in Tuvalu and supplies basic anaesthesia and essential medicines for in-country care, meaning ketamine — when clinically required for anaesthesia — would be obtained and used within the hospital’s formulary and supply procedures rather than via a dedicated psychedelic-treatment reimbursement pathway #.

There is no evidence of a national reimbursed program for ketamine as a psychiatric treatment (e.g., for depression) or of a formal esketamine reimbursement/registration process in Tuvalu; advanced psychiatric uses would likely require off-island referral or special import licences. The overall procurement and referral model in Tuvalu relies heavily on the single national hospital and overseas referrals for specialist care, with no publicly documented insurance/reimbursement scheme for novel psychedelic medicines # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Import, sale and possession would fall under the Dangerous Drugs / Pharmacy & Poisons regulatory regime and require Ministerial licensing if any medical use were proposed # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Any importation, supply or research would require express licensing by the relevant Tuvalu authorities under existing poisons and dangerous-drug laws # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Tuvalu has no known licenced ibogaine treatment programs and the statutory import/sale controls would apply to any proposed use # #.

Because ayahuasca contains DMT (a controlled tryptamine) its use is effectively controlled under national drug and poisons statutes; there is no authorised medical or religious exemption on record in Tuvalu and no reimbursement for any ceremonial or therapeutic use. Importation or distribution would be subject to licensing or prohibition under the Pharmacy and Poisons Act and Dangerous Drugs Act # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Any activity involving mescaline would be regulated by Tuvalu’s dangerous drugs and poisons laws and require ministerial/licensing approvals if proposed for research or medical use # #.

Currently classified as a strictly controlled substance (or would be captured by analogue/controlled-substance provisions) under Tuvalu’s drug-control framework, with no authorised medical use outside of approved clinical research. Designer phenethylamines such as the 2C series would be subject to the same importation, licensing and criminal provisions under the Dangerous Drugs and Pharmacy/Poisons statutes # #.